Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-069583
Filing Date
2009-03-31
Accepted
2009-03-31 17:08:19
Documents
13
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 263065
2 EXHIBIT 13.1 dex131.htm EX-13.1 544095
3 EXHIBIT 23.1 dex231.htm EX-23.1 1507
4 EXHIBIT 23.2 dex232.htm EX-23.2 1604
5 EXHIBIT 31.1 dex311.htm EX-31.1 9597
6 EXHIBIT 31.2 dex312.htm EX-31.2 9602
7 EXHIBIT 32.1 dex321.htm EX-32.1 3240
8 EXHIBIT 32.2 dex322.htm EX-32.2 3240
9 GRAPHIC g49393g00t34.jpg GRAPHIC 3393
10 GRAPHIC g49393g17c53.jpg GRAPHIC 20693
11 GRAPHIC g49393g60p35.jpg GRAPHIC 8576
12 GRAPHIC g49393g78b90.jpg GRAPHIC 10167
13 GRAPHIC g49393g97l06.jpg GRAPHIC 2145
  Complete submission text file 0001193125-09-069583.txt   900060
Mailing Address 601 BIOTECH DRIVE RICHMOND VA 23235
Business Address 601 BIOTECH DRIVE RICHMOND VA 23235 8046483820
COMMONWEALTH BIOTECHNOLOGIES INC (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 09720000
SIC: 8731 Services-Commercial Physical & Biological Research